Does EFGARTIGIMOD ALFA Cause Hyperlipidaemia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hyperlipidaemia have been filed in association with EFGARTIGIMOD ALFA (VYVGART). This represents 2.0% of all adverse event reports for EFGARTIGIMOD ALFA.
5
Reports of Hyperlipidaemia with EFGARTIGIMOD ALFA
2.0%
of all EFGARTIGIMOD ALFA reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hyperlipidaemia From EFGARTIGIMOD ALFA?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFGARTIGIMOD ALFA. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does EFGARTIGIMOD ALFA Cause?
Myasthenia gravis (46)
Off label use (39)
Drug ineffective (25)
Myasthenia gravis crisis (25)
Fatigue (22)
Pneumonia (20)
Muscular weakness (17)
Urinary tract infection (17)
Malaise (14)
Covid-19 (13)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which EFGARTIGIMOD ALFA Alternatives Have Lower Hyperlipidaemia Risk?
EFGARTIGIMOD ALFA vs EFGARTIGIMOD ALFA-FCAB
EFGARTIGIMOD ALFA vs EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC
EFGARTIGIMOD ALFA vs EFINACONAZOLE
EFGARTIGIMOD ALFA vs EFLORNITHINE
EFGARTIGIMOD ALFA vs EFMOROCTOCOG ALFA